Related references
Note: Only part of the references are listed.Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
Laura-Sophie Landwehr et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis
Tengda Li et al.
CANCER CELL INTERNATIONAL (2020)
N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
Zewei Tu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
Na Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
SNP2APA: a database for evaluating effects of genetic variants on alternative polyadenylation in human cancers
Yanbo Yang et al.
NUCLEIC ACIDS RESEARCH (2020)
The Critical Role of RNA m6A Methylation in Cancer
Qing Lan et al.
CANCER RESEARCH (2019)
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression updates through inhibiting BNIP3
Yi Niu et al.
MOLECULAR CANCER (2019)
LncRNA HOTAIR in Tumor Microenvironment: What Role?
Gerardo Botti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The role of m6A RNA methylation in human cancer
Xiao-Yu Chen et al.
MOLECULAR CANCER (2019)
Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
Hailing Shi et al.
MOLECULAR CELL (2019)
CANCER Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response
Rajarsi Mandal et al.
SCIENCE (2019)
miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer
Tianzhen Wang et al.
CELL DEATH & DISEASE (2019)
m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
Seungwon Yang et al.
NATURE COMMUNICATIONS (2019)
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma
Guillaume Assie et al.
JAMA ONCOLOGY (2019)
m6A mRNA methylation sustains Treg suppressive functions
Jiyu Tong et al.
CELL RESEARCH (2018)
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
Ying Yang et al.
CELL RESEARCH (2018)
Emerging function of N6-methyladenosine in cancer
Kwonho Hong
ONCOLOGY LETTERS (2018)
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim et al.
GASTROENTEROLOGY (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Aberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer
Natalia Pinello et al.
CANCER BIOLOGY & MEDICINE (2018)
miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma
Marta Diaz-Martinez et al.
CANCER RESEARCH (2018)
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians
Michael Allgaeuer et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Post-transcriptional gene regulation by mRNA modifications
Boxuan Simen Zhao et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
Xun Wang et al.
IMMUNOLOGY LETTERS (2017)
RNA m6A methylation regulates the ultraviolet-induced DNA damage response
Yang Xiang et al.
NATURE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events
Claudio R. Alarcon et al.
CELL (2015)
Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study
Jonathan D. Wasserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
N6-methyladenosine marks primary microRNAs for processing
Claudio R. Alarcon et al.
NATURE (2015)
Structural imprints in vivo decode RNA regulatory mechanisms
Robert C. Spitale et al.
NATURE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation
Shay Geula et al.
SCIENCE (2015)
Adrenocortical Carcinoma
Tobias Else et al.
ENDOCRINE REVIEWS (2014)
Functions of lncRNA HOTAIR in lung cancer
Gregory Loewen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Integrated genomic characterization of adrenocortical carcinoma
Guillaume Assie et al.
NATURE GENETICS (2014)
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
Jun-Hao Li et al.
NUCLEIC ACIDS RESEARCH (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
Feng Li et al.
CELL (2013)
RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian Clock
Jean-Michel Fustin et al.
CELL (2013)
miRcode: a map of putative microRNA target sites in the long non-coding transcriptome
Ashwini Jeggari et al.
BIOINFORMATICS (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinomas
Martin Fassnacht et al.
CANCER (2009)
Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma
Ricardo J. Gonzalez et al.
SURGERY (2007)
Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs
John L. Rinn et al.
CELL (2007)
Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress?
E Kebebew et al.
WORLD JOURNAL OF SURGERY (2006)
Clinical review: Adrenocortical carcinoma: Clinical update
Bruno Allolio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)